Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

224 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sézary T cells.
Rook AH, Vowels BR, Jaworsky C, Singh A, Lessin SR. Rook AH, et al. Arch Dermatol. 1993 Apr;129(4):486-9. Arch Dermatol. 1993. PMID: 8466223 No abstract available.
Effectiveness of photopheresis in Sézary syndrome.
Stevens SR, Bowen GM, Duvic M, King LE, Knobler R, Lim HW, Margolis D, Parry EJ, Rook AH, Stricklin GP, Suchin KR, Tharp MD, Vonderheid E, Zic JA. Stevens SR, et al. Among authors: rook ah. Arch Dermatol. 1999 Aug;135(8):995-7. doi: 10.1001/archderm.135.8.995-a. Arch Dermatol. 1999. PMID: 10456362 No abstract available.
The sign of Leser-Trélat in association with Sézary syndrome: simultaneous disappearance of seborrheic keratoses and malignant T-cell clone during combined therapy with photopheresis and interferon alfa.
Cohen JH, Lessin SR, Vowels BR, Benoit B, Witmer WK, Rook AH. Cohen JH, et al. Among authors: rook ah. Arch Dermatol. 1993 Sep;129(9):1213-5. Arch Dermatol. 1993. PMID: 8395792 No abstract available.
Th2 cytokine profile in cutaneous T-cell lymphoma.
Lessin SR, Vowels BR, Rook AH. Lessin SR, et al. Among authors: rook ah. J Invest Dermatol. 1995 Dec;105(6):855-6. doi: 10.1111/1523-1747.ep12326693. J Invest Dermatol. 1995. PMID: 7490483 No abstract available.
De novo development of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphoma.
Wolfe JT, Singh A, Lessin SR, Jaworsky C, Rook AH. Wolfe JT, et al. Among authors: rook ah. J Am Acad Dermatol. 1995 May;32(5 Pt 2):887-93. doi: 10.1016/0190-9622(95)91555-9. J Am Acad Dermatol. 1995. PMID: 7722051
Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma with interferon alfa and bexarotene therapy.
French LE, Shapiro M, Junkins-Hopkins JM, Vittorio CC, Rook AH. French LE, et al. Among authors: rook ah. J Am Acad Dermatol. 2001 Dec;45(6):914-8. doi: 10.1067/mjd.2001.117519. J Am Acad Dermatol. 2001. PMID: 11712039
The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma.
Rook AH, Kubin M, Fox FE, Niu Z, Cassin M, Vowels BR, Gottleib SL, Vonderheid EC, Lessin SR, Trinchieri G. Rook AH, et al. Ann N Y Acad Sci. 1996 Oct 31;795:310-8. doi: 10.1111/j.1749-6632.1996.tb52680.x. Ann N Y Acad Sci. 1996. PMID: 8958942
Increased interleukin 5 production in eosinophilic Sézary syndrome: regulation by interferon alfa and interleukin 12.
Suchin KR, Cassin M, Gottleib SL, Sood S, Cucchiara AJ, Vonderheid EC, Rook AH. Suchin KR, et al. Among authors: rook ah. J Am Acad Dermatol. 2001 Jan;44(1):28-32. doi: 10.1067/mjd.2001.109853. J Am Acad Dermatol. 2001. PMID: 11148473
Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution.
Gottlieb SL, Wolfe JT, Fox FE, DeNardo BJ, Macey WH, Bromley PG, Lessin SR, Rook AH. Gottlieb SL, et al. Among authors: rook ah. J Am Acad Dermatol. 1996 Dec;35(6):946-57. doi: 10.1016/s0190-9622(96)90119-x. J Am Acad Dermatol. 1996. PMID: 8959954
The immunopathogenesis of cutaneous T-cell lymphoma.
Rook AH, Heald P. Rook AH, et al. Hematol Oncol Clin North Am. 1995 Oct;9(5):997-1010. Hematol Oncol Clin North Am. 1995. PMID: 8522492 Review.
224 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page